ArticleFrontiers in public health2026
City- and county-level gaps in diabetes mortality improvement in the southeastern coastal region of China from 2005 to 2020, with provincial-level projections to 2030.
Article in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: The growing health and economic burden of diabetes in China is a result of fast urbanization and lifestyle changes. This highlights the critical need for a comprehensive analysis of epidemiological patterns and forecasts in order to achieve the "Healthy China 2030" goals. Methods: Socio-Demographic Index (SDI) factors were used to evaluate data on diabetes mortality and YLL (2005-2020) for adults in 84 Fujian counties. Age-Period-Cohort (APC) models were used to examine the impacts of age, period, and birth cohort, while frontier analysis identified areas for health improvement. Bayesian APC (BAPC) modeling was used to forecast future mortality through 2030. Results: Standardized mortality and YLL rates indicated considerable promise for improvement in high SDI cities like Xiamen and Fuzhou. Age-period-cohort analysis reveals that diabetes mortality increased dramatically with age, reaching 464.79/100,000 for those 85 and older. The mortality risk decreased in subsequent generations after peaking in the 1947 birth cohort (RR = 1.51). Bayesian projections suggest the standardized mortality rate will rise to 17.14/100,000 by 2030, with a greater impact on females. Diabetes-related deaths are expected to rise by 58.88% (to 10,891). Conclusion: High-SDI areas like Xiamen and Fuzhou require optimized resource allocation to reduce mortality. Targeted interventions for older adults are required due to aging and cohort effects. As the 2030 burden intensifies, strengthening early screening and regional strategies is essential to mitigate future impacts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.